Home › Funds › SB INVESTMENT ADVISERS (UK) LTD › DNA

SB INVESTMENT ADVISERS (UK) LTD position in DNA

GINKGO BIOWORKS HOLDINGS INC · Health Care

SB INVESTMENT ADVISERS (UK) LTD reported holding 610,729 shares of DNA (GINKGO BIOWORKS HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 0.13% of its reported portfolio and ranking #9 among its reported holdings. SB INVESTMENT ADVISERS (UK) LTD has disclosed DNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)610.73K sh
Reported value held$7.84M
Portfolio Weight0.13%
First reportedQ3 2023
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How SB INVESTMENT ADVISERS (UK) LTD's DNA position evolved

SB INVESTMENT ADVISERS (UK) LTD first disclosed a stake in DNA in Q3 2023 at 24,429,191 shares (US$44.2M). Across 13 filings, SB INVESTMENT ADVISERS (UK) LTD increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 610,729 shares valued at US$7.8M. Notable position changes include a 98% trim in Q3 2024 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 24.43M $44.22M New
Q4 2023 24.43M $41.29M Hold
Q1 2024 24.43M $28.34M Hold
Q2 2024 24.43M $8.17M Hold
Q3 2024 610.73K $4.98M Reduce
Q4 2024 610.73K $6.00M Hold
Q1 2025 610.73K $3.48M Hold
Q2 2025 610.73K $6.87M Hold
Q3 2025 610.73K $8.90M Hold
Q4 2025 610.73K $5.08M Hold
Q1 2026 610.73K $3.74M Hold
Q2 2026 610.73K $6.05M Hold
Q3 2026 610.73K $7.84M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNA and 13F data

DNA (GINKGO BIOWORKS HOLDINGS INC) is a Health Care company. 33 other funds we track also report a position in DNA — the largest reported positions include Anchorage Capital Group, L.L.C. (US$22.4M), FORBES J M & CO LLP (US$12.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNA

All DNA fund holders →

FAQ

How long has SB INVESTMENT ADVISERS (UK) LTD held DNA?

SB INVESTMENT ADVISERS (UK) LTD has disclosed DNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SB INVESTMENT ADVISERS (UK) LTD's current position in DNA?

As of Q3 2026, SB INVESTMENT ADVISERS (UK) LTD holds 610.73K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $7.84M, representing 0.13% of its reported portfolio and ranking #9.

Has SB INVESTMENT ADVISERS (UK) LTD been buying or selling DNA?

In the latest 13F filing (Q3 2026), SB INVESTMENT ADVISERS (UK) LTD held unchanged its position in DNA.

Which other funds hold DNA?

Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.